Stromal interaction molecule 1 polymorphisms are associated with coronary artery dilation but not with aneurysm formation in patients with kawasaki disease

Journal of Experimental and Clinical Medicine(Taiwan)

Volumn 5, Issue 2, 2013, Pages 73-76

  Hsu, Yu Wen ^a   Chien, Shu Chen ^a,f   Liang, Chi Cheng ^b   Yang, Kuender D ^c   Chang, Wei Pin ^d   Lee, Jen Ai ^a   Kuo, Ho Chang ^e   Chang, Wei Chiao ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^d YUANPEI UNIVERSITY   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Coronary artery dilation; Kawasaki disease; Stromal interaction molecule 1

Indexed keywords

IMMUNOGLOBULIN; STROMAL INTERACTION MOLECULE 1;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DILATATION; FEMALE; GENE FREQUENCY; GENE STRUCTURE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; STROMAL INTERACTION MOLECULE 1 GENE;

EID: 84876100751     PISSN: 18783317     EISSN: 18783325     Source Type: Journal    
DOI: 10.1016/j.jecm.2013.02.004     Document Type: Article

References (33)

1. Kawasaki T., Kosaki F., Okawa S., Shigematsu I., Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974, 54:271-276.
2. Huang W.C., Huang L.M., Chang I.S., Chang L.Y., Chiang B.L., Chen P.J., Wu M.H., et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 2009, 123:e401-e405.
3. Wang C.L., Wu Y.T., Liu C.A., Kuo H.C., Yang K.D. Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J 2005, 24:998-1004.
4. Burns J.C., Glodé M.P. Kawasaki syndrome. Lancet 2004, 364:533-544.
5. Newburger J.W., Takahashi M., Gerber M.A., Gewitz M.H., Tani L.Y., Burns J.C., Shulman S.T., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004, 110:2747-2771.
6. Kuo H.C., Wang C.L., Liang C.D., Yu H.R., Huang C.F., Wang L., Hwang K.P., et al. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease. Pediatr Allergy Immunol 2009, 20:266-272.
7. Kuo H.C., Wang C.L., Liang C.D., Yu H.R., Chen H.H., Wang L., Yang K.D. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease. J Microbiol Immunol Infect 2007, 40:395-400.
8. Vella A., Cooper J.D., Lowe C.E., Walker N., Nutland S., Widmer B., Jones R., et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 2005, 76:773-779.
9. Kuo H.C., Yu H.R., Juo S.H., Yang K.D., Wang Y.S., Liang C.D., Chen W.C., et al. CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children. J Hum Genet 2011, 56:161-165.
10. Kuo H.C., Yang K.D., Liang C.D., Bong C.N., Yu H.R., Wang L., Wang C.L. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol 2007, 18:354-359.
11. Chen S.Y., Wan L., Huang Y.C., Sheu J.J., Lan Y.C., Lai C.H., Lin C.W., et al. Interleukin-18 gene 105A/C genetic polymorphism is associated with the susceptibility of Kawasaki disease. J Clin Lab Anal 2009, 23:71-76.
12. Kuo H.C., Chang W.C. Genetic polymorphisms in Kawasaki disease. Acta Pharmacol Sin 2011, 32:1193-1198.
13. Onouchi Y., Gunji T., Burns J.C., Shimizu C., Newburger J.W., Yashiro M., Nakamura Y., et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008, 40:35-42.
14. Kuo H.C., Yang K.D., Juo S.H., Liang C.D., Chen W.C., Wang Y.S., Lee C.H., et al. ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population. PLoS One 2011, 6:e17370.
15. 2+ entry in the cardiomyocyte. Circulation 2011, 124:766-768.
16. Picard C., McCarl C.A., Papolos A., Khalil S., Lüthy K., Hivroz C., LeDeist F., et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 2009, 360:1971-1980.
17. Kuo H.C., Liang C.D., Yu H.R., Wang C.L., Lin I.C., Liu C.A., Chang J.C., et al. CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease. J Clin Immunol 2011, 31:240-244.
18. Kuo H.C., Liang C.D., Wang C.L., Yu H.R., Hwang K.P., Yang K.D. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Acta Paediatr 2010, 99:1578-1583.
19. Yu H.R., Kuo H.C., Sheen J.M., Wang L., Lin I.C., Wang C.L., Yang K.D. A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease. Pediatr Allergy Immunol 2009, 20:699-707.
20. Shulman S.T., De Inocencio J., Hirsch R. Kawasaki disease. Pediatr Clin North Am 1995, 42:1205-1222.
21. JCS Joint Working Group Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)-digest version. Circ J 2010, 74:1989-2020.
22. Onouchi Y., Onoue S., Tamari M., Wakui K., Fukushima Y., Yashiro M., Nakamura Y., et al. CD40 ligand gene and Kawasaki disease. Eur J Hum Genet 2004, 12:1062-1068.
23. Beiser A.S., Takahashi M., Baker A.L., Sundel R.P., Newburger J.W. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol 1998, 81:1116-1120.
24. McCrindle B.W., McIntyre S., Kim C., Lin T., Adeli K. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?. J Pediatr 2007, 151:244-248. 248.e1.
25. Silva A.A., Maeno Y., Hashmi A., Smallhorn J.F., Silverman E.D., McCrindle B.W. Cardiovascular risk factors after Kawasaki disease: a case-control study. J Pediatr 2001, 138:400-405.
26. Tsuda E., Kamiya T., Kimura K., Ono Y., Echigo S. Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening. Pediatr Cardiol 2002, 23:9-14.
27. Parekh A.B., Fleig A., Penner R. The store-operated calcium current I(CRAC): nonlinear activation by InsP3 and dissociation from calcium release. Cell 1997, 89:973-980.
28. Voelkers M., Salz M., Herzog N., Frank D., Dolatabadi N., Frey N., Gude N., et al. Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. J Mol Cell Cardiol 2010, 48:1329-1334.
29. Abdullaev I.F., Bisaillon J.M., Potier M., Gonzalez J.C., Motiani R.K., Trebak M. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 2008, 103:1289-1299.
30. Wang J.Y., Chen B.K., Wang Y.S., Tsai Y.T., Chen W.C., Chang W.C., Hou M.F., et al. Involvement of store-operated calcium signaling in EGF-mediated COX-2 gene activation in cancer cells. Cell Signal 2012, 24:162-169.
31. Wei J.C., Hung K.S., Hsu Y.W., Wong R.H., Huang C.H., Jan M.S., Wu S.J., et al. Genetic polymorphisms of stromal interaction molecule 1 associated with the erythrocyte sedimentation rate and C-reactive protein in HLA-B27 positive ankylosing spondylitis patients. PLoS One 2012, 7:e49698.
32. Onouchi Y., Ozaki K., Burns J.C., Shimizu C., Terai M., Hamada H., Honda T., et al. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 2012, 44:517-521.
33. Sauna Z.E., Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 2011, 12:683-691.